Review



human neuroblastoma nb cell lines sk n be 2 c  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC human neuroblastoma nb cell lines sk n be 2 c
    (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic <t>SK-N-BE(2)-C,</t> NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.
    Human Neuroblastoma Nb Cell Lines Sk N Be 2 C, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 461 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+neuroblastoma+nb+cell+lines/BE(2)-C/pmc13105273-47-0-35
    Average 96 stars, based on 461 article reviews
    human neuroblastoma nb cell lines sk n be 2 c - by Bioz Stars, 2026-09
    96/100 stars

    Images

    1) Product Images from "QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp–overexpressing cancer models"

    Article Title: QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp–overexpressing cancer models

    Journal: Molecular cancer therapeutics

    doi: 10.1158/1535-7163.MCT-25-1013

    (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic SK-N-BE(2)-C, NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.
    Figure Legend Snippet: (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic SK-N-BE(2)-C, NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.

    Techniques Used: Binding Assay, Reflux, Control, Western Blot, Staining, Immunofluorescence, Comparison

    (A) Representative images and quantification of colony formation in BE2C/VCR cells treated with QW-5–70, vincristine, or colchicine (1–5 nM). (B) Colony formation assays in PC-3/TxR cells treated with QW-5–70, paclitaxel, or colchicine (1–5 nM). Colony area is expressed as mean ± SEM relative to vehicle control (n = 5). (C) Transwell migration of BE2C/VCR (left) and PC-3/TxR (right) cells after 24 h treatment with vincristine or paclitaxel (5 nM) or QW-5–70 (2 or 5 nM). (D) Transwell migration of BE2C/VCR (left) and PC-3/TxR (right) cells treated with QW-5–70 (0.5–5 nM) for 24 h. Migration area is expressed as mean ± SEM relative to control (n = 5). Scale bar = 100 μm. (E) Immunoblot analysis of P-gp expression in SK-N-BE(2)-C and BE2C/VCR cells. (F) Viability of BE2C/VCR cells treated with QW-5–70 or vincristine (0.1 nM–3 μM) in the absence or presence of verapamil (10 μM) for 72 h (MTS assay; n = 4). (G) Intracellular concentrations of QW-5–70 and vincristine in parental SK-N-BE(2)-C and BE2C/VCR cells following 50 nM, 2 h treatment, with or without tariquidar (1 μM), quantified by LC–MS/MS (n = 3). (H) Immunoblot analysis of P-gp expression in PC-3 and PC-3/TxR cells. (I) Cell viability of PC-3/TxR cells treated with QW-5–70 or paclitaxel (0.1 nM–3 μM) in the absence or presence of verapamil (10 μM) for 72 h (MTS assay; n = 4). (J) Intracellular concentrations of QW-5–70 and paclitaxel in PC-3 and PC-3/TxR cells under the same conditions as panel G, quantified by LC–MS/MS (n = 3). (K) Immunoblot analysis of P-gp expression in PC-3/TxR cells following transfection with scrambled control or si-P-gp. GAPDH served as a loading control. (L) Viability of QW-5–70 and paclitaxel in PC-3/TxR, PC-3/TxR-scramble, and PC-3/TxR-si-P-gp cells (MTS assay; n=4).
    Figure Legend Snippet: (A) Representative images and quantification of colony formation in BE2C/VCR cells treated with QW-5–70, vincristine, or colchicine (1–5 nM). (B) Colony formation assays in PC-3/TxR cells treated with QW-5–70, paclitaxel, or colchicine (1–5 nM). Colony area is expressed as mean ± SEM relative to vehicle control (n = 5). (C) Transwell migration of BE2C/VCR (left) and PC-3/TxR (right) cells after 24 h treatment with vincristine or paclitaxel (5 nM) or QW-5–70 (2 or 5 nM). (D) Transwell migration of BE2C/VCR (left) and PC-3/TxR (right) cells treated with QW-5–70 (0.5–5 nM) for 24 h. Migration area is expressed as mean ± SEM relative to control (n = 5). Scale bar = 100 μm. (E) Immunoblot analysis of P-gp expression in SK-N-BE(2)-C and BE2C/VCR cells. (F) Viability of BE2C/VCR cells treated with QW-5–70 or vincristine (0.1 nM–3 μM) in the absence or presence of verapamil (10 μM) for 72 h (MTS assay; n = 4). (G) Intracellular concentrations of QW-5–70 and vincristine in parental SK-N-BE(2)-C and BE2C/VCR cells following 50 nM, 2 h treatment, with or without tariquidar (1 μM), quantified by LC–MS/MS (n = 3). (H) Immunoblot analysis of P-gp expression in PC-3 and PC-3/TxR cells. (I) Cell viability of PC-3/TxR cells treated with QW-5–70 or paclitaxel (0.1 nM–3 μM) in the absence or presence of verapamil (10 μM) for 72 h (MTS assay; n = 4). (J) Intracellular concentrations of QW-5–70 and paclitaxel in PC-3 and PC-3/TxR cells under the same conditions as panel G, quantified by LC–MS/MS (n = 3). (K) Immunoblot analysis of P-gp expression in PC-3/TxR cells following transfection with scrambled control or si-P-gp. GAPDH served as a loading control. (L) Viability of QW-5–70 and paclitaxel in PC-3/TxR, PC-3/TxR-scramble, and PC-3/TxR-si-P-gp cells (MTS assay; n=4).

    Techniques Used: Activity Assay, Expressing, Control, Migration, Western Blot, MTS Assay, Liquid Chromatography with Mass Spectroscopy, Transfection

    (A) Cell-cycle distribution of SK-N-BE(2)-C, NB-1691, and PC-3/TxR cells treated with QW-5–70 (2 or 5 nM) for 24 h, analyzed by flow cytometry (n=3). (B, C) Immunoblot analysis of cell-cycle–related proteins (phospho-histone H3 (Ser10), histone H3, cyclin B1, phospho-CDK1 (Thr161), and CDK1) in parental (SK-N-BE(2)-C, NB-1691) and resistant (BE2C/VCR, PC-3/TxR) cells treated with QW-5–70 (2 or 5 nM) for 24 h. (D, E) Immunoblot analysis of apoptosis-related proteins (cCas9, cCas3, PARP, cPARP, p-BCL2 (Ser70), and BCL2) in the same cell lines following 24 h treatment. GAPDH served as a loading control.
    Figure Legend Snippet: (A) Cell-cycle distribution of SK-N-BE(2)-C, NB-1691, and PC-3/TxR cells treated with QW-5–70 (2 or 5 nM) for 24 h, analyzed by flow cytometry (n=3). (B, C) Immunoblot analysis of cell-cycle–related proteins (phospho-histone H3 (Ser10), histone H3, cyclin B1, phospho-CDK1 (Thr161), and CDK1) in parental (SK-N-BE(2)-C, NB-1691) and resistant (BE2C/VCR, PC-3/TxR) cells treated with QW-5–70 (2 or 5 nM) for 24 h. (D, E) Immunoblot analysis of apoptosis-related proteins (cCas9, cCas3, PARP, cPARP, p-BCL2 (Ser70), and BCL2) in the same cell lines following 24 h treatment. GAPDH served as a loading control.

    Techniques Used: Flow Cytometry, Western Blot, Control

    (A) SK-N-BE(2)-c cells were treated with five doses of QW-5–70 (0.125 to 2 nM) in combination with five doses of DFMO (10–1000 μM). Cell viability was assessed using the MTS assay (n=4). (B) CI–Fa analysis of the QW-5–70 and DFMO combination. CI values were calculated using the Chou–Talalay median-effect method for five experimentally tested dose pairs at their corresponding Fa values. CI < 1, CI = 1, and CI > 1 indicate synergistic, additive, and antagonistic interactions, respectively. (C) SK-N-BE(2)-c cells were treated with five doses of QW-5–70 (0.125 to 2 nM) in combination with five doses of MLN8237 (1–100 nM). Cell viability was assessed using the MTS assay (n=4). (D) SK-N-BE(2)-C cells were treated with 1 nM QW-5–70 in combination with either DFMO (300 μM, top) or MLN8237 (30 nM, bottom) as indicated. Cell lysates were analyzed by immunoblotting for cPARP as a marker of apoptosis, with GAPDH used as a loading control. (E) Representative colony formation images of SK-N-BE(2)-C cells treated with the same combination. Colony formations were quantified and expressed as mean ± SEM relative to vehicle (set to 100%) (n=5).
    Figure Legend Snippet: (A) SK-N-BE(2)-c cells were treated with five doses of QW-5–70 (0.125 to 2 nM) in combination with five doses of DFMO (10–1000 μM). Cell viability was assessed using the MTS assay (n=4). (B) CI–Fa analysis of the QW-5–70 and DFMO combination. CI values were calculated using the Chou–Talalay median-effect method for five experimentally tested dose pairs at their corresponding Fa values. CI < 1, CI = 1, and CI > 1 indicate synergistic, additive, and antagonistic interactions, respectively. (C) SK-N-BE(2)-c cells were treated with five doses of QW-5–70 (0.125 to 2 nM) in combination with five doses of MLN8237 (1–100 nM). Cell viability was assessed using the MTS assay (n=4). (D) SK-N-BE(2)-C cells were treated with 1 nM QW-5–70 in combination with either DFMO (300 μM, top) or MLN8237 (30 nM, bottom) as indicated. Cell lysates were analyzed by immunoblotting for cPARP as a marker of apoptosis, with GAPDH used as a loading control. (E) Representative colony formation images of SK-N-BE(2)-C cells treated with the same combination. Colony formations were quantified and expressed as mean ± SEM relative to vehicle (set to 100%) (n=5).

    Techniques Used: Activity Assay, MTS Assay, Western Blot, Marker, Control

    Related Articles

    Multiple Displacement Amplification:

    Article Title: Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers
    Article Snippet: 7 Enhanced Chemiluminescence Reagent was purchased from Amersham Biosciences (Piscataway, NJ) and the Protein Assay Kit was purchased from Bio-Rad Laboratories (Hercules, CA). fig ft0 fig mode=article f1 caption a4 Chemical structure and identities of CFM-1, -4, 5, and CFM-4 analogs CFM-4.1–4.6. .. Human NSCLC cell lines A549, CALU-C3, H1299, and H460, human TNBC cell lines MDA-MB-468, MDA-MB-231, HCC1937, and Hs578T, as well as human neuroblastoma (NB) cell lines SK-N-BE(2) and SK-N-SH were purchased from ATCC, and were kindly provided by Drs. Sandro daRocha, Julie Boerner, Jing Li, and Yubin Ge, Departments of Chemical Engineering and Materials Science, Oncology and Pharmacology, Wayne State University, Detroit, MI. ..

    Article Title: Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers
    Article Snippet: Establishment of Sub-Cutaneous Tumors in SCID Mice Three week-old, female, ICR SCID mice were obtained from Taconic Laboratories (German Town, NY). .. Cells and Cell Culture Human NSCLC cell lines A549, CALU-C3, H1299, and H460, human TNBC cell lines MDA-MB-468, MDA-MB-231, HCC1937, and Hs578T, as well as human neuroblastoma (NB) cell lines SK-N-BE(2) and SK-N-SH were purchased from ATCC, and were kindly provided by Drs. Sandro daRocha, Julie Boerner, Jing Li, and Yubin Ge, Departments of Chemical Engineering and Materials Science, Oncology and Pharmacology, Wayne State University, Detroit, MI. ..

    Article Title: Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.
    Article Snippet: Generation and characterization of the anti-CARP-1/CCAR1 rabbit polyclonal antibodies have been described elsewhere.7 Enhanced Chemiluminescence Reagent was purchased from Amersham Biosciences (Piscataway, NJ) and the Protein Assay Kit was purchased from Bio-Rad Laboratories (Hercules, CA). .. Cells and Cell Culture Human NSCLC cell lines A549, CALU-C3, H1299, and H460, human TNBC cell lines MDA-MB-468, MDAMB-231, HCC1937, and Hs578T, as well as human neuroblastoma (NB) cell lines SK-N-BE(2) and SK-N-SH were purchased from ATCC, and were kindly provided by Drs. Sandro daRocha, Julie Boerner, Jing Li, and Yubin Ge, Departments of Chemical Engineering and Materials Science, Oncology and Pharmacology, Wayne State University, Detroit, MI. ..

    Immunopeptidomics:

    Article Title: Natural Killer Cells from the Subcutaneous Adipose Tissue Underexpress the NKp30 and NKp44 in Obese Persons and Are Less Active against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells
    Article Snippet: .. The human neuroblastoma (NB) cell lines of SK-NSH (ATCC-HTB11TM) and CHLA255 (DSMZ-Germany), both were negative for MHC-I have been used in this study. ..

    Cell Culture:

    Article Title: Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers
    Article Snippet: Establishment of Sub-Cutaneous Tumors in SCID Mice Three week-old, female, ICR SCID mice were obtained from Taconic Laboratories (German Town, NY). .. Cells and Cell Culture Human NSCLC cell lines A549, CALU-C3, H1299, and H460, human TNBC cell lines MDA-MB-468, MDA-MB-231, HCC1937, and Hs578T, as well as human neuroblastoma (NB) cell lines SK-N-BE(2) and SK-N-SH were purchased from ATCC, and were kindly provided by Drs. Sandro daRocha, Julie Boerner, Jing Li, and Yubin Ge, Departments of Chemical Engineering and Materials Science, Oncology and Pharmacology, Wayne State University, Detroit, MI. ..

    Article Title: Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.
    Article Snippet: Generation and characterization of the anti-CARP-1/CCAR1 rabbit polyclonal antibodies have been described elsewhere.7 Enhanced Chemiluminescence Reagent was purchased from Amersham Biosciences (Piscataway, NJ) and the Protein Assay Kit was purchased from Bio-Rad Laboratories (Hercules, CA). .. Cells and Cell Culture Human NSCLC cell lines A549, CALU-C3, H1299, and H460, human TNBC cell lines MDA-MB-468, MDAMB-231, HCC1937, and Hs578T, as well as human neuroblastoma (NB) cell lines SK-N-BE(2) and SK-N-SH were purchased from ATCC, and were kindly provided by Drs. Sandro daRocha, Julie Boerner, Jing Li, and Yubin Ge, Departments of Chemical Engineering and Materials Science, Oncology and Pharmacology, Wayne State University, Detroit, MI. ..



    Similar Products

    96
    ATCC human neuroblastoma nb cell lines sk n be 2 c
    (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic <t>SK-N-BE(2)-C,</t> NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.
    Human Neuroblastoma Nb Cell Lines Sk N Be 2 C, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+neuroblastoma+nb+cell+lines/BE(2)-C/pmc13105273-47-0-35
    Average 96 stars, based on 1 article reviews
    human neuroblastoma nb cell lines sk n be 2 c - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    97
    ATCC sk n as human neuroblastoma nb cell line
    (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic <t>SK-N-BE(2)-C,</t> NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.
    Sk N As Human Neuroblastoma Nb Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+neuroblastoma+nb+cell+lines/TIBx%3B+Epithelial+liver%3B+Mouse/10__1016_slash_j__jeurceramsoc__2025__117384-105-1-10
    Average 97 stars, based on 1 article reviews
    sk n as human neuroblastoma nb cell line - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    ATCC cell culture human neuroblastoma nb tumor cell lines imr 32
    (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic <t>SK-N-BE(2)-C,</t> NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.
    Cell Culture Human Neuroblastoma Nb Tumor Cell Lines Imr 32, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+neuroblastoma+nb+cell+lines/IMR-32/pm38039964-213-3-23
    Average 97 stars, based on 1 article reviews
    cell culture human neuroblastoma nb tumor cell lines imr 32 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    95
    ATCC m17 human neuroblastoma cell line nb atcc cat no crl 2267
    (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic <t>SK-N-BE(2)-C,</t> NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.
    M17 Human Neuroblastoma Cell Line Nb Atcc Cat No Crl 2267, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+neuroblastoma+nb+cell+lines/BE(2)-M17/pmc10135514-41-2-8
    Average 95 stars, based on 1 article reviews
    m17 human neuroblastoma cell line nb atcc cat no crl 2267 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    96
    ATCC undifferentiated human neuroblastoma nb cell lines
    Immunofluorescence assay using a polyclonal antibody to SARS-CoV-2 nucleoprotein antigens to detect SARS-CoV-2 antigen expression on the cell surface of SARS-CoV-2 infected and uninfected <t>neuroblastoma</t> cell lines. (Top row, left to right): TC-268 uninfected; TC-268 SARS-CoV-2 infected; JFEN uninfected; JFEN SARS-CoV-2 infected, (Second row, left to right): CRL-2266 uninfected; CRL-2266 SARS-CoV-2 infected; CRL-2267 uninfected; CRL-2267 SARS-CoV-2 infected, (Third row, left to right): CRL-2142 uninfected; CRL-2142 SARS-CoV-2 infected; CRL-2149 uninfected; CRL-2149 SARS-CoV-2 infected, and (Bottom row, left to right): CRL-2271 uninfected; CRL-2271 SARS-CoV-2 infected; CRL-127 uninfected; CRL-127- SARS-CoV-2 infected. Magnification = 40 ×.
    Undifferentiated Human Neuroblastoma Nb Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+neuroblastoma+nb+cell+lines/IMR-32%3B+Neuroblastoma%3B+Human/pmc08551687-67-1-10
    Average 96 stars, based on 1 article reviews
    undifferentiated human neuroblastoma nb cell lines - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    ATCC human neuroblastoma nb cell lines
    Immunofluorescence assay using a polyclonal antibody to SARS-CoV-2 nucleoprotein antigens to detect SARS-CoV-2 antigen expression on the cell surface of SARS-CoV-2 infected and uninfected <t>neuroblastoma</t> cell lines. (Top row, left to right): TC-268 uninfected; TC-268 SARS-CoV-2 infected; JFEN uninfected; JFEN SARS-CoV-2 infected, (Second row, left to right): CRL-2266 uninfected; CRL-2266 SARS-CoV-2 infected; CRL-2267 uninfected; CRL-2267 SARS-CoV-2 infected, (Third row, left to right): CRL-2142 uninfected; CRL-2142 SARS-CoV-2 infected; CRL-2149 uninfected; CRL-2149 SARS-CoV-2 infected, and (Bottom row, left to right): CRL-2271 uninfected; CRL-2271 SARS-CoV-2 infected; CRL-127 uninfected; CRL-127- SARS-CoV-2 infected. Magnification = 40 ×.
    Human Neuroblastoma Nb Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+neuroblastoma+nb+cell+lines/SK-N-AS/pm30870485-56-1-22
    Average 96 stars, based on 1 article reviews
    human neuroblastoma nb cell lines - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    99
    ATCC human neuroblastoma cell line nb
    ( A ) Effect of FNIII14 for proliferation of <t>IMR-32</t> cells. IMR-32 cells adhered on the fibronectin substrate were stimulated with or without FNIII14 (50 μg/mL) for 5 days and then subjected to the WST assay, as described in ‘Materials and Methods’. Each point represents the mean ± S.D. of triplicate determinations, * P < 0.05. ( B and C ) Effect of FNIII14 on the expression of MYCN gene and N-Myc protein. IMR-32 cells were stimulated with the indicated concentrations of FNIII14 for 6 days and then subjected to real-time PCR (B) or Western blot analysis (C). ( D ) Time-dependent decrease in N-Myc protein levels by FNIII14. IMR-32 cells were stimulated with FNIII14 (50 μg/mL) for the indicated days and then subjected to Western blot analysis to detect N-Myc protein. In (C) and (D), the intensity of the immunoblot was quantified densitometrically and represented as relative intensity.
    Human Neuroblastoma Cell Line Nb, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+neuroblastoma+nb+cell+lines/SH-SY5Y%3B+Neuroblastoma%3B+Human/pmc06697639-122-0-8
    Average 99 stars, based on 1 article reviews
    human neuroblastoma cell line nb - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic SK-N-BE(2)-C, NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.

    Journal: Molecular cancer therapeutics

    Article Title: QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp–overexpressing cancer models

    doi: 10.1158/1535-7163.MCT-25-1013

    Figure Lengend Snippet: (A) General Synthesis of QW-5–70. i). 60% NaH, SEMCl, THF, 0–25 °C; ii). n-BuLi, 3,4,5-trimethoxybenzaldehyde, THF, −78 °C; iii). Dess-Martin, CH 2 Cl 2 , r.t.; iv)1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, Pd(PPh 3 ) 4 , Na 2 CO 3 , 1,4-dioxane/H 2 O (v/v = 2/1), reflux; v). Pd(OAC) 2 , PPh 3 , K 2 CO 3 , n-butanol, reflux; vi). 37% HCl, MeOH, reflux. (B) QW-5–70 induced tubulin depolymerization. Colchicine and paclitaxel were included as reference compounds. (C) SPR sensorgrams of QW-5–70 and colchicine binding to tubulin. (mean ± SEM, n = 3) (D) EBI competition assays. The upper β-tubulin band represents native β-tubulin, while the lower band corresponds to the EBI–β-tubulin adduct. GAPDH served as a loading control. (E) Immunoblot analysis of soluble and polymerized β-tubulin in PC-3 cells following treatment with QW-5–70, colchicine, or paclitaxel (20 nM). Cells were fractionated into soluble and polymerized tubulin pools, which were analyzed by immunoblotting. Ponceau S staining and GAPDH were used as loading controls for polymerized and soluble fractions, respectively. Quantification of polymerized β-tubulin expressed as a percentage of total β-tubulin (soluble + polymerized). (mean ± SEM, n=3). (F) Representative immunofluorescence images of interphase and mitotic SK-N-BE(2)-C, NB-1691, and PC-3 cells treated with QW-5–70 (2 nM and 5 nM) for 24 h. Microtubules were stained with anti-α-tubulin antibodies (red), and nuclei were counterstained with DAPI (blue). Scale bar = 50 μm (n=3). (G) High-resolution X-ray crystal structure of the sT2R complex with QW-5–70. Left panel: detailed interactions of QW-5–70 (green sticks) within the colchicine-binding site are shown. Bound water molecules are represented as red spheres, and hydrogen bonds are indicated by dashed magenta lines. The electron density for QW-5–70 is shown as a blue mesh; the final 2Fo-Fc map is contoured at 1.0 σ. Middle panel: detailed interactions of colchicine (light-brown sticks) binding to sT2R (PDB 6XER) for comparison. Right panel: superposition of sT2R complexes with QW-5–70 and colchicine sT2R (colored grey) complexes, highlighting the relative inhibitor binding positions and differing conformations of the α-T5 and β-T7 loops.

    Article Snippet: Human neuroblastoma (NB) cell lines (SK-N-BE(2)-C, RRID: CVCL_0529; NB-1691, RRID: CVCL_5628; SK-N-BE(2), RRID: CVCL_0528; SiMa, RRID: CVCL_1695; IMR-32, RRID: CVCL_0346) and prostate cancer cell lines (PC-3, RRID: CVCL_0035; 22Rv1, RRID: CVCL_1045) were originally obtained from ATCC in 2019.

    Techniques: Binding Assay, Reflux, Control, Western Blot, Staining, Immunofluorescence, Comparison

    (A) Representative images and quantification of colony formation in BE2C/VCR cells treated with QW-5–70, vincristine, or colchicine (1–5 nM). (B) Colony formation assays in PC-3/TxR cells treated with QW-5–70, paclitaxel, or colchicine (1–5 nM). Colony area is expressed as mean ± SEM relative to vehicle control (n = 5). (C) Transwell migration of BE2C/VCR (left) and PC-3/TxR (right) cells after 24 h treatment with vincristine or paclitaxel (5 nM) or QW-5–70 (2 or 5 nM). (D) Transwell migration of BE2C/VCR (left) and PC-3/TxR (right) cells treated with QW-5–70 (0.5–5 nM) for 24 h. Migration area is expressed as mean ± SEM relative to control (n = 5). Scale bar = 100 μm. (E) Immunoblot analysis of P-gp expression in SK-N-BE(2)-C and BE2C/VCR cells. (F) Viability of BE2C/VCR cells treated with QW-5–70 or vincristine (0.1 nM–3 μM) in the absence or presence of verapamil (10 μM) for 72 h (MTS assay; n = 4). (G) Intracellular concentrations of QW-5–70 and vincristine in parental SK-N-BE(2)-C and BE2C/VCR cells following 50 nM, 2 h treatment, with or without tariquidar (1 μM), quantified by LC–MS/MS (n = 3). (H) Immunoblot analysis of P-gp expression in PC-3 and PC-3/TxR cells. (I) Cell viability of PC-3/TxR cells treated with QW-5–70 or paclitaxel (0.1 nM–3 μM) in the absence or presence of verapamil (10 μM) for 72 h (MTS assay; n = 4). (J) Intracellular concentrations of QW-5–70 and paclitaxel in PC-3 and PC-3/TxR cells under the same conditions as panel G, quantified by LC–MS/MS (n = 3). (K) Immunoblot analysis of P-gp expression in PC-3/TxR cells following transfection with scrambled control or si-P-gp. GAPDH served as a loading control. (L) Viability of QW-5–70 and paclitaxel in PC-3/TxR, PC-3/TxR-scramble, and PC-3/TxR-si-P-gp cells (MTS assay; n=4).

    Journal: Molecular cancer therapeutics

    Article Title: QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp–overexpressing cancer models

    doi: 10.1158/1535-7163.MCT-25-1013

    Figure Lengend Snippet: (A) Representative images and quantification of colony formation in BE2C/VCR cells treated with QW-5–70, vincristine, or colchicine (1–5 nM). (B) Colony formation assays in PC-3/TxR cells treated with QW-5–70, paclitaxel, or colchicine (1–5 nM). Colony area is expressed as mean ± SEM relative to vehicle control (n = 5). (C) Transwell migration of BE2C/VCR (left) and PC-3/TxR (right) cells after 24 h treatment with vincristine or paclitaxel (5 nM) or QW-5–70 (2 or 5 nM). (D) Transwell migration of BE2C/VCR (left) and PC-3/TxR (right) cells treated with QW-5–70 (0.5–5 nM) for 24 h. Migration area is expressed as mean ± SEM relative to control (n = 5). Scale bar = 100 μm. (E) Immunoblot analysis of P-gp expression in SK-N-BE(2)-C and BE2C/VCR cells. (F) Viability of BE2C/VCR cells treated with QW-5–70 or vincristine (0.1 nM–3 μM) in the absence or presence of verapamil (10 μM) for 72 h (MTS assay; n = 4). (G) Intracellular concentrations of QW-5–70 and vincristine in parental SK-N-BE(2)-C and BE2C/VCR cells following 50 nM, 2 h treatment, with or without tariquidar (1 μM), quantified by LC–MS/MS (n = 3). (H) Immunoblot analysis of P-gp expression in PC-3 and PC-3/TxR cells. (I) Cell viability of PC-3/TxR cells treated with QW-5–70 or paclitaxel (0.1 nM–3 μM) in the absence or presence of verapamil (10 μM) for 72 h (MTS assay; n = 4). (J) Intracellular concentrations of QW-5–70 and paclitaxel in PC-3 and PC-3/TxR cells under the same conditions as panel G, quantified by LC–MS/MS (n = 3). (K) Immunoblot analysis of P-gp expression in PC-3/TxR cells following transfection with scrambled control or si-P-gp. GAPDH served as a loading control. (L) Viability of QW-5–70 and paclitaxel in PC-3/TxR, PC-3/TxR-scramble, and PC-3/TxR-si-P-gp cells (MTS assay; n=4).

    Article Snippet: Human neuroblastoma (NB) cell lines (SK-N-BE(2)-C, RRID: CVCL_0529; NB-1691, RRID: CVCL_5628; SK-N-BE(2), RRID: CVCL_0528; SiMa, RRID: CVCL_1695; IMR-32, RRID: CVCL_0346) and prostate cancer cell lines (PC-3, RRID: CVCL_0035; 22Rv1, RRID: CVCL_1045) were originally obtained from ATCC in 2019.

    Techniques: Activity Assay, Expressing, Control, Migration, Western Blot, MTS Assay, Liquid Chromatography with Mass Spectroscopy, Transfection

    (A) Cell-cycle distribution of SK-N-BE(2)-C, NB-1691, and PC-3/TxR cells treated with QW-5–70 (2 or 5 nM) for 24 h, analyzed by flow cytometry (n=3). (B, C) Immunoblot analysis of cell-cycle–related proteins (phospho-histone H3 (Ser10), histone H3, cyclin B1, phospho-CDK1 (Thr161), and CDK1) in parental (SK-N-BE(2)-C, NB-1691) and resistant (BE2C/VCR, PC-3/TxR) cells treated with QW-5–70 (2 or 5 nM) for 24 h. (D, E) Immunoblot analysis of apoptosis-related proteins (cCas9, cCas3, PARP, cPARP, p-BCL2 (Ser70), and BCL2) in the same cell lines following 24 h treatment. GAPDH served as a loading control.

    Journal: Molecular cancer therapeutics

    Article Title: QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp–overexpressing cancer models

    doi: 10.1158/1535-7163.MCT-25-1013

    Figure Lengend Snippet: (A) Cell-cycle distribution of SK-N-BE(2)-C, NB-1691, and PC-3/TxR cells treated with QW-5–70 (2 or 5 nM) for 24 h, analyzed by flow cytometry (n=3). (B, C) Immunoblot analysis of cell-cycle–related proteins (phospho-histone H3 (Ser10), histone H3, cyclin B1, phospho-CDK1 (Thr161), and CDK1) in parental (SK-N-BE(2)-C, NB-1691) and resistant (BE2C/VCR, PC-3/TxR) cells treated with QW-5–70 (2 or 5 nM) for 24 h. (D, E) Immunoblot analysis of apoptosis-related proteins (cCas9, cCas3, PARP, cPARP, p-BCL2 (Ser70), and BCL2) in the same cell lines following 24 h treatment. GAPDH served as a loading control.

    Article Snippet: Human neuroblastoma (NB) cell lines (SK-N-BE(2)-C, RRID: CVCL_0529; NB-1691, RRID: CVCL_5628; SK-N-BE(2), RRID: CVCL_0528; SiMa, RRID: CVCL_1695; IMR-32, RRID: CVCL_0346) and prostate cancer cell lines (PC-3, RRID: CVCL_0035; 22Rv1, RRID: CVCL_1045) were originally obtained from ATCC in 2019.

    Techniques: Flow Cytometry, Western Blot, Control

    (A) SK-N-BE(2)-c cells were treated with five doses of QW-5–70 (0.125 to 2 nM) in combination with five doses of DFMO (10–1000 μM). Cell viability was assessed using the MTS assay (n=4). (B) CI–Fa analysis of the QW-5–70 and DFMO combination. CI values were calculated using the Chou–Talalay median-effect method for five experimentally tested dose pairs at their corresponding Fa values. CI < 1, CI = 1, and CI > 1 indicate synergistic, additive, and antagonistic interactions, respectively. (C) SK-N-BE(2)-c cells were treated with five doses of QW-5–70 (0.125 to 2 nM) in combination with five doses of MLN8237 (1–100 nM). Cell viability was assessed using the MTS assay (n=4). (D) SK-N-BE(2)-C cells were treated with 1 nM QW-5–70 in combination with either DFMO (300 μM, top) or MLN8237 (30 nM, bottom) as indicated. Cell lysates were analyzed by immunoblotting for cPARP as a marker of apoptosis, with GAPDH used as a loading control. (E) Representative colony formation images of SK-N-BE(2)-C cells treated with the same combination. Colony formations were quantified and expressed as mean ± SEM relative to vehicle (set to 100%) (n=5).

    Journal: Molecular cancer therapeutics

    Article Title: QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp–overexpressing cancer models

    doi: 10.1158/1535-7163.MCT-25-1013

    Figure Lengend Snippet: (A) SK-N-BE(2)-c cells were treated with five doses of QW-5–70 (0.125 to 2 nM) in combination with five doses of DFMO (10–1000 μM). Cell viability was assessed using the MTS assay (n=4). (B) CI–Fa analysis of the QW-5–70 and DFMO combination. CI values were calculated using the Chou–Talalay median-effect method for five experimentally tested dose pairs at their corresponding Fa values. CI < 1, CI = 1, and CI > 1 indicate synergistic, additive, and antagonistic interactions, respectively. (C) SK-N-BE(2)-c cells were treated with five doses of QW-5–70 (0.125 to 2 nM) in combination with five doses of MLN8237 (1–100 nM). Cell viability was assessed using the MTS assay (n=4). (D) SK-N-BE(2)-C cells were treated with 1 nM QW-5–70 in combination with either DFMO (300 μM, top) or MLN8237 (30 nM, bottom) as indicated. Cell lysates were analyzed by immunoblotting for cPARP as a marker of apoptosis, with GAPDH used as a loading control. (E) Representative colony formation images of SK-N-BE(2)-C cells treated with the same combination. Colony formations were quantified and expressed as mean ± SEM relative to vehicle (set to 100%) (n=5).

    Article Snippet: Human neuroblastoma (NB) cell lines (SK-N-BE(2)-C, RRID: CVCL_0529; NB-1691, RRID: CVCL_5628; SK-N-BE(2), RRID: CVCL_0528; SiMa, RRID: CVCL_1695; IMR-32, RRID: CVCL_0346) and prostate cancer cell lines (PC-3, RRID: CVCL_0035; 22Rv1, RRID: CVCL_1045) were originally obtained from ATCC in 2019.

    Techniques: Activity Assay, MTS Assay, Western Blot, Marker, Control

    Immunofluorescence assay using a polyclonal antibody to SARS-CoV-2 nucleoprotein antigens to detect SARS-CoV-2 antigen expression on the cell surface of SARS-CoV-2 infected and uninfected neuroblastoma cell lines. (Top row, left to right): TC-268 uninfected; TC-268 SARS-CoV-2 infected; JFEN uninfected; JFEN SARS-CoV-2 infected, (Second row, left to right): CRL-2266 uninfected; CRL-2266 SARS-CoV-2 infected; CRL-2267 uninfected; CRL-2267 SARS-CoV-2 infected, (Third row, left to right): CRL-2142 uninfected; CRL-2142 SARS-CoV-2 infected; CRL-2149 uninfected; CRL-2149 SARS-CoV-2 infected, and (Bottom row, left to right): CRL-2271 uninfected; CRL-2271 SARS-CoV-2 infected; CRL-127 uninfected; CRL-127- SARS-CoV-2 infected. Magnification = 40 ×.

    Journal: Oman Medical Journal

    Article Title: Infectivity of Human Olfactory Neurons to SARS-CoV-2: A Link to Anosmia

    doi: 10.5001/omj.2021.128

    Figure Lengend Snippet: Immunofluorescence assay using a polyclonal antibody to SARS-CoV-2 nucleoprotein antigens to detect SARS-CoV-2 antigen expression on the cell surface of SARS-CoV-2 infected and uninfected neuroblastoma cell lines. (Top row, left to right): TC-268 uninfected; TC-268 SARS-CoV-2 infected; JFEN uninfected; JFEN SARS-CoV-2 infected, (Second row, left to right): CRL-2266 uninfected; CRL-2266 SARS-CoV-2 infected; CRL-2267 uninfected; CRL-2267 SARS-CoV-2 infected, (Third row, left to right): CRL-2142 uninfected; CRL-2142 SARS-CoV-2 infected; CRL-2149 uninfected; CRL-2149 SARS-CoV-2 infected, and (Bottom row, left to right): CRL-2271 uninfected; CRL-2271 SARS-CoV-2 infected; CRL-127 uninfected; CRL-127- SARS-CoV-2 infected. Magnification = 40 ×.

    Article Snippet: Six undifferentiated human neuroblastoma (NB) cell lines were purchased from ATCC (New York, NY).

    Techniques: Immunofluorescence, Expressing, Infection

    ( A ) Effect of FNIII14 for proliferation of IMR-32 cells. IMR-32 cells adhered on the fibronectin substrate were stimulated with or without FNIII14 (50 μg/mL) for 5 days and then subjected to the WST assay, as described in ‘Materials and Methods’. Each point represents the mean ± S.D. of triplicate determinations, * P < 0.05. ( B and C ) Effect of FNIII14 on the expression of MYCN gene and N-Myc protein. IMR-32 cells were stimulated with the indicated concentrations of FNIII14 for 6 days and then subjected to real-time PCR (B) or Western blot analysis (C). ( D ) Time-dependent decrease in N-Myc protein levels by FNIII14. IMR-32 cells were stimulated with FNIII14 (50 μg/mL) for the indicated days and then subjected to Western blot analysis to detect N-Myc protein. In (C) and (D), the intensity of the immunoblot was quantified densitometrically and represented as relative intensity.

    Journal: Oncotarget

    Article Title: Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

    doi: 10.18632/oncotarget.27131

    Figure Lengend Snippet: ( A ) Effect of FNIII14 for proliferation of IMR-32 cells. IMR-32 cells adhered on the fibronectin substrate were stimulated with or without FNIII14 (50 μg/mL) for 5 days and then subjected to the WST assay, as described in ‘Materials and Methods’. Each point represents the mean ± S.D. of triplicate determinations, * P < 0.05. ( B and C ) Effect of FNIII14 on the expression of MYCN gene and N-Myc protein. IMR-32 cells were stimulated with the indicated concentrations of FNIII14 for 6 days and then subjected to real-time PCR (B) or Western blot analysis (C). ( D ) Time-dependent decrease in N-Myc protein levels by FNIII14. IMR-32 cells were stimulated with FNIII14 (50 μg/mL) for the indicated days and then subjected to Western blot analysis to detect N-Myc protein. In (C) and (D), the intensity of the immunoblot was quantified densitometrically and represented as relative intensity.

    Article Snippet: Human neuroblastoma cell line NB-1 was obtained from ATCC, cultured with RPMI1640 medium plus 10% FBS, 2 mM glutamine, penicillin-streptomycin solution, and 2.2 g/L NaHCO 3 .

    Techniques: WST Assay, Expressing, Real-time Polymerase Chain Reaction, Western Blot

    ( A and B ) Involvement of proteasomal degradation in FNIII14-induced decrease in N-Myc protein. IMR-32 cells were cultured in the presence or absence of FNIII14 (50 μg/mL). MG-132, a proteasome inhibitor, was added to this culture on day 5, and cell lysates on day 6 were subjected to Western blot analysis using N-Myc Ab (A). Immunoprecipitation study using anti-N-Myc Ab was performed in (B), as described in “Material and Methods”. Cell lysates were also subjected to immunoblot analysis to detect ubiquitination of N-Myc protein. ( C ) Effect of FNIII14 on gene expression of integrin subunits. IMR-32 cells stimulated with or without FNIII14 (50 μg/mL) for 6 days were subjected to RT-PCR to detect integrin gene of β1 (ITGB1), α4 (ITGA4), α5 (ITGA5) and αv (ITGAV). ( D ) Effect of FNIII14 on integrin β1 protein expression. IMR-32 cells treated as in (C) were subjected to Western blot analysis to detect N-Myc protein. ( E and F ) Involvement of β1-integrin inactivation in FNIII14-induced N-Myc protein degradation. IMR-32 cells were stimulated with or without FNIII14 (50 μg/mL) in the presence or absence of factors that affect the β1-mediated cell adhesion: HUTS-4 = β1-integrin-activating mAb, MnCl2 = integrin activator, RGD and CS-1 = antagonistic peptides for integrin αvβ1 and α4β1, respectively. After 6 days of culture, cells were subjected to Western blot analysis using anti-N-Myc Ab. In (A) and (D–F), the intensity of the immunoblots was quantified densitometrically and represented as relative intensity.

    Journal: Oncotarget

    Article Title: Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

    doi: 10.18632/oncotarget.27131

    Figure Lengend Snippet: ( A and B ) Involvement of proteasomal degradation in FNIII14-induced decrease in N-Myc protein. IMR-32 cells were cultured in the presence or absence of FNIII14 (50 μg/mL). MG-132, a proteasome inhibitor, was added to this culture on day 5, and cell lysates on day 6 were subjected to Western blot analysis using N-Myc Ab (A). Immunoprecipitation study using anti-N-Myc Ab was performed in (B), as described in “Material and Methods”. Cell lysates were also subjected to immunoblot analysis to detect ubiquitination of N-Myc protein. ( C ) Effect of FNIII14 on gene expression of integrin subunits. IMR-32 cells stimulated with or without FNIII14 (50 μg/mL) for 6 days were subjected to RT-PCR to detect integrin gene of β1 (ITGB1), α4 (ITGA4), α5 (ITGA5) and αv (ITGAV). ( D ) Effect of FNIII14 on integrin β1 protein expression. IMR-32 cells treated as in (C) were subjected to Western blot analysis to detect N-Myc protein. ( E and F ) Involvement of β1-integrin inactivation in FNIII14-induced N-Myc protein degradation. IMR-32 cells were stimulated with or without FNIII14 (50 μg/mL) in the presence or absence of factors that affect the β1-mediated cell adhesion: HUTS-4 = β1-integrin-activating mAb, MnCl2 = integrin activator, RGD and CS-1 = antagonistic peptides for integrin αvβ1 and α4β1, respectively. After 6 days of culture, cells were subjected to Western blot analysis using anti-N-Myc Ab. In (A) and (D–F), the intensity of the immunoblots was quantified densitometrically and represented as relative intensity.

    Article Snippet: Human neuroblastoma cell line NB-1 was obtained from ATCC, cultured with RPMI1640 medium plus 10% FBS, 2 mM glutamine, penicillin-streptomycin solution, and 2.2 g/L NaHCO 3 .

    Techniques: Cell Culture, Western Blot, Immunoprecipitation, Ubiquitin Proteomics, Gene Expression, Reverse Transcription Polymerase Chain Reaction, Expressing

    IMR-32 cells adhered on the fibronectin substrate were cultured with or without FNIII14 (50 μg/mL) for 6 days. Cell lysates were subjected to Western blot analysis. ( A ) Effects of FNIII14 for phosphorylation levels of GSK3β at Ser9 and Akt at Ser473. ( B ) Effects of FNIII14 for intracellular level of Fbxw7 protein and Aurora A protein. The intensity of the immunoblot was quantified densitometrically and represented as relative intensity.

    Journal: Oncotarget

    Article Title: Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

    doi: 10.18632/oncotarget.27131

    Figure Lengend Snippet: IMR-32 cells adhered on the fibronectin substrate were cultured with or without FNIII14 (50 μg/mL) for 6 days. Cell lysates were subjected to Western blot analysis. ( A ) Effects of FNIII14 for phosphorylation levels of GSK3β at Ser9 and Akt at Ser473. ( B ) Effects of FNIII14 for intracellular level of Fbxw7 protein and Aurora A protein. The intensity of the immunoblot was quantified densitometrically and represented as relative intensity.

    Article Snippet: Human neuroblastoma cell line NB-1 was obtained from ATCC, cultured with RPMI1640 medium plus 10% FBS, 2 mM glutamine, penicillin-streptomycin solution, and 2.2 g/L NaHCO 3 .

    Techniques: Cell Culture, Western Blot, Phospho-proteomics

    ( A and B ) Effect of FNIII14 on anchorage-independent cell growth. IMR-32 cells treated with (gray bar) or without FNIII14 (open bar) for 6 days were subjected to the colony formation assay as described in ‘Materials and Methods’. (A): Number of colonies formed after 3 weeks. (B): Representative images of colonies in “Control” (without FNIII14) (a) and “FNIII14” (with FNIII14) (b). ( C ) Effect of FNIII14 on the invasion ability of IMR-32. IMR-32 cells treated with (gray bar) or without FNIII14 (open bar) for 6 days were subjected to the in vitro invasion assay as described in ‘Materials and Methods’. Each point represents the mean ± S.D. of triplicate determinations, ** P < 0.01.

    Journal: Oncotarget

    Article Title: Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

    doi: 10.18632/oncotarget.27131

    Figure Lengend Snippet: ( A and B ) Effect of FNIII14 on anchorage-independent cell growth. IMR-32 cells treated with (gray bar) or without FNIII14 (open bar) for 6 days were subjected to the colony formation assay as described in ‘Materials and Methods’. (A): Number of colonies formed after 3 weeks. (B): Representative images of colonies in “Control” (without FNIII14) (a) and “FNIII14” (with FNIII14) (b). ( C ) Effect of FNIII14 on the invasion ability of IMR-32. IMR-32 cells treated with (gray bar) or without FNIII14 (open bar) for 6 days were subjected to the in vitro invasion assay as described in ‘Materials and Methods’. Each point represents the mean ± S.D. of triplicate determinations, ** P < 0.01.

    Article Snippet: Human neuroblastoma cell line NB-1 was obtained from ATCC, cultured with RPMI1640 medium plus 10% FBS, 2 mM glutamine, penicillin-streptomycin solution, and 2.2 g/L NaHCO 3 .

    Techniques: Colony Assay, Control, In Vitro, Invasion Assay

    IMR-32 cells (2.0 × 10 6 cells/head) suspended in MEM containing EHS-gel were subcutaneously injected into the left flank of Balb/c nude mice. Mice bearing established tumors were divided into two groups: the Control group was administered vehicle and the FNIII14 group was administered peptide FNIII14, as described in the Materials and Methods. Chemotherapy was initially carried out for 1 week. Tumor volume (mm 3 ) was determined by measuring with calipers and calculated according to hemi-ellipsoid model: Volume = 2/3 × π × (major axis/2) × (minor axis/2) 2 . Three weeks after chemotherapy, tumors removed from mice were subjected to western blot analysis to detect N-Myc and Aurora A as described in the ‘Materials and Methods’. ( A ) Tumor growth curves for IMR-32 xenografts (Control group, n = 5; FNIII14 group, n = 4). Tumor volumes are shown as means ± S.E. Data was analyzed by Mann-Whitney U -test. ( B ) Representative dot plots showing the tumor volume for each week. ( C ) Body weight of each group. ( D ) Expression of N-Myc and Aurora A proteins in tumor tissues of the Control and FNIII14 groups.

    Journal: Oncotarget

    Article Title: Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

    doi: 10.18632/oncotarget.27131

    Figure Lengend Snippet: IMR-32 cells (2.0 × 10 6 cells/head) suspended in MEM containing EHS-gel were subcutaneously injected into the left flank of Balb/c nude mice. Mice bearing established tumors were divided into two groups: the Control group was administered vehicle and the FNIII14 group was administered peptide FNIII14, as described in the Materials and Methods. Chemotherapy was initially carried out for 1 week. Tumor volume (mm 3 ) was determined by measuring with calipers and calculated according to hemi-ellipsoid model: Volume = 2/3 × π × (major axis/2) × (minor axis/2) 2 . Three weeks after chemotherapy, tumors removed from mice were subjected to western blot analysis to detect N-Myc and Aurora A as described in the ‘Materials and Methods’. ( A ) Tumor growth curves for IMR-32 xenografts (Control group, n = 5; FNIII14 group, n = 4). Tumor volumes are shown as means ± S.E. Data was analyzed by Mann-Whitney U -test. ( B ) Representative dot plots showing the tumor volume for each week. ( C ) Body weight of each group. ( D ) Expression of N-Myc and Aurora A proteins in tumor tissues of the Control and FNIII14 groups.

    Article Snippet: Human neuroblastoma cell line NB-1 was obtained from ATCC, cultured with RPMI1640 medium plus 10% FBS, 2 mM glutamine, penicillin-streptomycin solution, and 2.2 g/L NaHCO 3 .

    Techniques: Injection, Control, Western Blot, MANN-WHITNEY, Expressing

    ( A – C ) Induction of proteasome-dependent degradation of c-myc protein by FNIII14. Various cancer-derived cell lines (Pancreatic cancer MIA-PaCa 2 cells in (A), small cell lung cancer NCI-H82 cells in (B) and chronic myelogenous leukemia K562 cells in (C)) were cultured with each medium in the presence or absence of FNIII14 in the same manner as in the case of neuroblastoma cells IMR-32. MG-132 was similarly added one day before the end of FNIII14 treatment and treated for 24 hours. ( D ) Involvement of β1-integrin inactivation in FNIII14-induced c-myc protein degradation. MIA-PaCa 2 cells were stimulated with FNIII14 in the presence or absence of factors capable of β1-integrin activation, HUTS-4 and MnCl2. ( E ) Effect of FNIII14 on the anchorage-independent growth of MIA-PaCa 2 cells. MIA-PaCa 2 cells were subjected to the colony formation assay as described in ‘Materials and Methods’.

    Journal: Oncotarget

    Article Title: Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

    doi: 10.18632/oncotarget.27131

    Figure Lengend Snippet: ( A – C ) Induction of proteasome-dependent degradation of c-myc protein by FNIII14. Various cancer-derived cell lines (Pancreatic cancer MIA-PaCa 2 cells in (A), small cell lung cancer NCI-H82 cells in (B) and chronic myelogenous leukemia K562 cells in (C)) were cultured with each medium in the presence or absence of FNIII14 in the same manner as in the case of neuroblastoma cells IMR-32. MG-132 was similarly added one day before the end of FNIII14 treatment and treated for 24 hours. ( D ) Involvement of β1-integrin inactivation in FNIII14-induced c-myc protein degradation. MIA-PaCa 2 cells were stimulated with FNIII14 in the presence or absence of factors capable of β1-integrin activation, HUTS-4 and MnCl2. ( E ) Effect of FNIII14 on the anchorage-independent growth of MIA-PaCa 2 cells. MIA-PaCa 2 cells were subjected to the colony formation assay as described in ‘Materials and Methods’.

    Article Snippet: Human neuroblastoma cell line NB-1 was obtained from ATCC, cultured with RPMI1640 medium plus 10% FBS, 2 mM glutamine, penicillin-streptomycin solution, and 2.2 g/L NaHCO 3 .

    Techniques: Derivative Assay, Cell Culture, Activation Assay, Colony Assay